Ozempic and Wegovy Lawsuits

Which shots the cases name

The cases name several shots, made by two companies.

• Novo Nordisk makes Ozempic, Wegovy, Rybelsus, Saxenda and Victoza.
• Eli Lilly makes Mounjaro, Zepbound and Trulicity.

They all work the same basic way. They slow down how fast your stomach empties, which is part of why you feel full. The lawsuits say that for some people the stomach slowed too much and stayed that way, even after they stopped taking the shot. Ozempic, Wegovy and Mounjaro come up most often in the filings.

The health problems people report

Four kinds of harm come up most often in the stomach cases.

• Gastroparesis. Some doctors call it stomach paralysis. The stomach muscles stop pushing food along. People feel sick, throw up, hurt, and cannot eat normally.
• Ileus. The intestines stop moving and nothing passes through. This one can turn into an emergency.
• Bowel blockage. Something gets stuck and food cannot get past it.
• Gallbladder trouble. Stones, swelling, or surgery to remove the gallbladder.

The eye cases are separate. People describe the sight in one eye going dim or dark over about a day. Doctors call it NAION. It usually does not come back.

Where the cases stand

The federal cases are sorted into two groups, both in front of the same judge in Philadelphia. Grouping cases this way is normal when many people sue over the same product. One judge handles the parts that are the same for everyone, like collecting company records. Each person still has their own case.

• Stomach cases. About 4,000 as of September 1, 2026. Two years earlier the number was closer to 1,000.
• Eye cases. 216 as of that same date. That group was created at the end of 2025 and started with 29.

New cases have been arriving at a rate of roughly 80 to 90 a month through 2026.

The test that matters for stomach claims

In August 2025 the judge ruled that anyone claiming stomach paralysis has to back it up with a properly performed gastric emptying study. That is a test measuring how long food actually takes to leave your stomach, and the court accepts three kinds: a scan after eating food containing a small, safe marker, a breath test, or a capsule you swallow that sends readings as it travels.

This ruling matters because most of the stomach cases rest on that diagnosis. Plenty of people were told they had gastroparesis based on symptoms alone and never had any of these tests. If you had one, the result is worth getting a copy of. How much it matters for any one person depends on what their records actually show, which is the kind of thing a lawyer reviews case by case.

What happens next

The judge is working through a big question right now. She has to decide whether the expert doctors and scientists hired by the injured people are allowed to testify about warnings and about what causes these injuries. She held a hearing on it in Philadelphia over five days, September 14 through 18, 2026.

That decision shapes everything after it. If those experts are allowed in, the cases move toward trials. If they are kept out, many of these cases could end. The judge has not ruled yet and there is no set date for it. Related briefing runs into October, so a decision is unlikely before then.

She has already ruled against the injured people once on a question like this. In the same August 2025 order that required a gastric emptying study, she barred two of their experts from testifying on how gastroparesis is diagnosed, and allowed the drug companies' expert to testify.

Some things have not happened yet, and it is worth being plain about them. Nobody has been paid. There is no settlement and no fund. No case has gone in front of a jury, and no trial date has been set. Anyone promising a payout from these cases today is describing something that does not exist.

What to keep

Whatever happens in court, a few records are worth holding onto.

• Pharmacy printouts showing the drug name and the dates you filled it.
• Hospital or emergency room paperwork, if you have any.
• A copy of any test result, especially a gastric emptying study.
• A note of roughly when you started the shot and when symptoms started.

Deadlines for filing are set by each state, and they keep running whether or not anything is happening in court. You can read more about how filing deadlines work, how mass torts work, or what evidence helps a lawsuit. If you want the research behind all of this, see does Ozempic cause gastroparesis.

Frequently Asked Questions

Is there a settlement yet?

No. No money has been paid, there is no settlement fund, and there is no claim form to fill out. The cases are still at the stage where lawyers argue in front of a judge about what evidence a jury would be allowed to hear.

Which shots are named in these cases?

Ozempic, Wegovy, Rybelsus, Saxenda and Victoza, which are made by Novo Nordisk, and Mounjaro, Zepbound and Trulicity, which are made by Eli Lilly. Ozempic, Wegovy and Mounjaro come up most often.

What is NAION?

NAION is sudden vision loss in one eye. Blood flow to the nerve behind the eye drops and sight in that eye fades fast, often within a day. It is usually permanent. Eye cases are handled separately from the stomach cases.

Should I stop taking my shot?

That is a question for your prescribing doctor, not for a web page and not for a lawyer. Stopping a diabetes or weight medicine on your own can cause its own problems. Bring your concerns to the person who prescribed it.

How long do cases like this usually take?

Years, not months. These cases were first grouped together in 2024 and no trial date has been set. Large drug cases often run five years or longer from beginning to end.

Sources

• Judicial Panel on Multidistrict Litigation, pending MDL report of September 1, 2026 (PDF) — the report the case counts on this page come from. It lists 4,022 actions in MDL 3094 and 216 in MDL 3163.
• Judicial Panel on Multidistrict Litigation, Pending MDLs — where a newer report is posted on the first business day of each month, if you want to check the current numbers yourself.
• Eastern District of Pennsylvania, official page for MDL 3094 — the court’s own page for the stomach injury cases, which names the drugs in the case and the presiding judge.
• Eastern District of Pennsylvania, official page for MDL 3163 — the court’s page for the NAION vision loss cases, which were separated from the stomach cases.
• Eastern District of Pennsylvania, orders in MDL 3094 — every order the judge has entered in the stomach cases. The gastric emptying study requirement is the memorandum order at ECF No. 468, signed August 15, 2025, which accepts scintigraphy, a breath test, or a wireless motility capsule.
• Scheduling order for the Rule 702 hearing, entered August 28, 2026 (PDF) — moved the hearing on the expert testimony to September 14 through 18, 2026.
• Court docket, In re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094, No. 2:24-md-03094-KSM (E.D. Pa.) — the case record itself, which is where the order numbers, hearing dates and case counts above were checked. It is available through PACER.

Figures and dates above should be confirmed against the original sources.